MEGACOM promout health
 
óêð
ðóñ
eng



 

 
Glianov / Hikma Pharmaceuticals


A third-generation sulfonylurea drug Indications: non-insulin-dependent II type diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate to control glycemia.

Dosage: The usual initial dose of Glianov is 1 mg once per day. If necessary the daily dose can be increased.

The dosage increase should be made in increments (1 mg – 2 mg – 3 mg- 4 mg – 6 mg) at 1-2 week intervals with regular monitor of blood sugar level.

A daily dose for patients with adequate compensation of diabetes mellitus usually is from 1 mg to 4 mg of Glianov.

Only some patients need to take 6 mg or more for adequate compensation of diabetes mellitus, the maximum daily dose may be 8 mg. The tablets are taken with plenty of water (not less than half a glass) before meals.

Drug dosage therapy is determined by a doctor taking into consideration a pace of life of a patient.

It is usually enough to take a daily dose once per day immediately before the first main meal. It is very important not to miss a meal after administration of Glianov.

31.12.11
Merry Christmas and Happy New Year! »
1.12.11
The seminar "Continuous professional development of the family doctor and pediatrician"  »
15.10.11
"Prevention, diagnosis and management of acute exacerbations of bronchial asthma" Scientific-Practical Conference »
5.10.11
XIII Sidelnikov's readings »
15.09.11
We shall overcome! »







© 2004 «MEGACOM»
All right reserved


MEGACOM

Home  Company  Pressroom    Partners  Products  Guestbook  Contacts


Developed by design studio PEREVOROT
May, 2005